Newborn screening increases survival outcome for patients with severe combined immunodeficiency

Severe combined immunodeficiency (SCID) occurs in just one out of every 50,000 to 100,000 births in the United States, yet it is the most serious primary immunodeficiency disorder. A new study demonstrates that babies with SCID who are diagnosed at birth and receive a hematopoietic stem cell transplant, which is the transplantation of blood-forming stem cells, have significantly improved survival.

Read the whole article on Science Daily

More from Science Daily